Comment On: “Can the EVIDEM Framework Tackle Issues Raised by Evaluating Treatments for Rare Diseases: Analysis of Issues and Policies, and Context-Specific Adaptation”
PharmacoEconomics - United Kingdom
doi 10.1007/s40273-017-0493-5
Full Text
Open PDFAbstract
Available in full text
Date
March 21, 2017
Authors
Publisher
Springer Science and Business Media LLC